Don’t discount the opportunity for a sooner than later buyout. It’s proven in animals and a cancer tumor in a dog, cat or horse is no different in humans. So it’s proven and with an IDE attached so It’s money in the bank. A perfect opportunity for any Oncology biotech with excess R&D budget in their annual plan. Spend it or lose it. Could be 1-3B candidate by the end of this fiscal year.
If you think nonprofit hospitals are in the business just to help people, and not make $$ you live in a fantasy world. My uncle is a CEO of an extremely large nonprofit in eastern PA and he freaking ruthless. Also take note of all the patents that institutions hold such as the Mayo Clinic, John’s Hopkins, Ohio State, etc.
Market Data 
Markets 
